Abstract
Aim In this study, we aimed to determine clinical usefulness and advantages of ordering tests that include total creatine kinase (CK), creatine kinase myocar- dial band (CK-MB, enzymatic), troponin I, myoglobin, and CK-MB (mass) in stat laboratory of our hospital with an assessment according to patients diagnoses in Usak region. Methods Four hundred thirty-eight patients presenting to Usak State Hospital Stat Laboratory between March 2010 and April 2010 were included in this study. CK, CK-MB (enzymatic), troponin I, myoglobin, and CK-MB (mass) levels, diagnosis, and hospitalization were evaluated. Results Among the total of 107 patients, 41 (9,3%) were hospitalized to coronary intensive care unit, 13 (2,9%) to cardiology service, 13 (2,9%) to chest disease service, 10 (2,2%) to internal medicine service, 10 (2,2%) to neurology service, 5 (1,1%) to chest disease intensive care unit, and 15 (3,4%) to other services (24,4%). The preliminary diagnosis and second diagnosis after hospitalization were found same (89.9%). Seventy-eight (17,8%) patients had troponin level over the upper reference limit of 0,06ng/mL (mean ± SD;5,130 ± 11,682 (0,06-50) ng/mL); 108 (24,6%) patients had myoglobin level over the upper reference limit of 110ng/mL. Sixteen (%3,65) patients were diagnosed with AMI. Conclusion In our study, we found that nearly half of the patients ordering cardiac marker tests in the stat clinical biochemistry laboratory were hospitalized associated with cardiovascular system services. The preliminary diagnosis and second diagnosis after hospitalization were found the same (89.9 %) and this value was evaluated as good in terms of clinical practice. Early diagnosis of acute coronary syndrome (ACS), hospitalization to an appropriate service, and treatment or timely invasive procedures are provided to shorten hospital stay and improve disease prognosis.